Navigation Links
GenTel BioSurfaces launches new assay platform

Madison, Wis. - GenTel BioSurfaces, Inc. has launched PATHT HTS, a new platform for high-throughput quantitative immunoassays. PATH HTS was introduced last week at the microarray industry's annual conference, Chips To Hits in Boston.

"Our customers have been very pleased with the performance of PATH protein microarray slides," said Robert Negm, vice president of business developmen......

Full article >>>
'"/>

Source:wistechnology.com By WTN News 09/20/05


Page: 1

Related biology technology :

1. GenTel acquires GlaxoSmithKline chip platform
2. New angel capital centered on GenTel agreement with big pharma
3. GenTel licenses next generation cancer research
4. GenTel to distribute cancer research tool
5. GenTel gets federal grant to develop allergy test
6. Madisons GenTel partners with Taiwan firm
7. Fisher Biosciences contracts with Madison-based GenTel BioSurfaces
8. GenTel will sell Dutch firms biomolecule labeling technology
9. Bone Care, GenTel, MyWeather
10. GenTel receives $250,000 state loan
11. GenTel claims $900,000 in federal grants this year for biochip research
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: GenTel BioSurfaces launches new assay platform

Breaking Biology News(10 mins):Springer signs co-publishing agreement with the Royal Swedish Academy of Sciences 2Improving the odds 2The Academy of Natural Sciences and Temple Press revive rare natural history work in new book 2Amicus Therapeutics Announces Third Quarter 2009 Financial Results and Strategic Business Updates 14656 1Amicus Therapeutics Announces Third Quarter 2009 Financial Results and Strategic Business Updates 14656 2Amicus Therapeutics Announces Third Quarter 2009 Financial Results and Strategic Business Updates 14656 3Amicus Therapeutics Announces Third Quarter 2009 Financial Results and Strategic Business Updates 14656 4Amicus Therapeutics Announces Third Quarter 2009 Financial Results and Strategic Business Updates 14656 5Amicus Therapeutics Announces Third Quarter 2009 Financial Results and Strategic Business Updates 14656 6Amicus Therapeutics Announces Third Quarter 2009 Financial Results and Strategic Business Updates 14656 7Amicus Therapeutics Announces Third Quarter 2009 Financial Results and Strategic Business Updates 14656 8Amicus Therapeutics Announces Third Quarter 2009 Financial Results and Strategic Business Updates 14656 9Amicus Therapeutics Announces Third Quarter 2009 Financial Results and Strategic Business Updates 14656 10Amicus Therapeutics Announces Third Quarter 2009 Financial Results and Strategic Business Updates 14656 11Amicus Therapeutics Announces Third Quarter 2009 Financial Results and Strategic Business Updates 14656 12Amicus Therapeutics Announces Third Quarter 2009 Financial Results and Strategic Business Updates 14656 13Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Third Quarter 2009 Financial Results on November 5 2009 14653 1Mettler Toledo International Inc Reports Third Quarter 2009 Results 5862 1Mettler Toledo International Inc Reports Third Quarter 2009 Results 5862 2Mettler Toledo International Inc Reports Third Quarter 2009 Results 5862 3Mettler Toledo International Inc Reports Third Quarter 2009 Results 5862 4Mettler Toledo International Inc Reports Third Quarter 2009 Results 5862 5Mettler Toledo International Inc Reports Third Quarter 2009 Results 5862 6Mettler Toledo International Inc Reports Third Quarter 2009 Results 5862 7Mettler Toledo International Inc Reports Third Quarter 2009 Results 5862 8Mettler Toledo International Inc Reports Third Quarter 2009 Results 5862 9Mettler Toledo International Inc Reports Third Quarter 2009 Results 5862 10Mettler Toledo International Inc Reports Third Quarter 2009 Results 5862 11Mettler Toledo International Inc Reports Third Quarter 2009 Results 5862 12Mettler Toledo International Inc Reports Third Quarter 2009 Results 5862 13